Miracle Mile Advisors’s Novartis NVS Stock Holding History

Miracle Mile Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Buy	4,439 +350	+9%	+$52.5K	0.01%	527
2026 Q1	$625K	Buy	4,089 +438	+12%	+$67.1K	0.01%	528
2025 Q4	$503K	Buy	3,651 +32	+0.9%	+$4.19K	0.01%	562
2025 Q3	$464K	Buy	3,619 +328	+10%	+$40K	0.01%	568
2025 Q2	$398K	Buy	+3,291	New	+$371K	0.01%	535

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Miracle Mile Advisors's NVS Position: Q2 2026 in Review

Miracle Mile Advisors increased its Novartis (NVS) stake by 8.6% in Q2 2026, buying an estimated $52.5K and bringing the position to 4,439 shares worth $696K. The position accounts for 0.01% of the portfolio, ranked #527.

Miracle Mile Advisors first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Miracle Mile Advisors held 4,439 shares of Novartis worth $696K as of Q2 2026.
Miracle Mile Advisors bought 350 Novartis shares in Q2 2026, an estimated $52.5K.
Novartis made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #527 holding.
Miracle Mile Advisors first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.